{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T10:04:37Z","timestamp":1789466677732,"version":"build-2803163510"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05708-4","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T14:46:49Z","timestamp":1785941209000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mendelian randomization analysis of inflammatory proteins and lung adenocarcinoma risk"],"prefix":"10.1007","volume":"17","author":[{"given":"Heyi","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,5]]},"reference":[{"issue":"1","key":"5708_CR1","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"CA Cancer J Clin"},{"issue":"10299","key":"5708_CR2","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S0140-6736(21)00312-3","volume":"398","author":"AA Thai","year":"2021","unstructured":"Thai AA, Solomon BJ, Sequist LV, Gainor JF, Heist RS. Lung cancer. Lancet. 2021;398(10299):535\u201354.","journal-title":"Lancet"},{"issue":"5","key":"5708_CR3","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1056\/NEJMoa1102873","volume":"365","author":"DR Aberle","year":"2011","unstructured":"National Lung Screening Trial Research Team, Aberle DR, Adams AM, Berg CD, Black WC, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5):395\u2013409.","journal-title":"N Engl J Med"},{"issue":"6","key":"5708_CR4","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/j.jtcvs.2012.07.012","volume":"144","author":"Y Tsutani","year":"2012","unstructured":"Tsutani Y, Miyata Y, Nakayama H, Okumura S, Adachi S, Yoshimura M, Okada M. Prediction of pathologic node-negative clinical stage IA lung adenocarcinoma for optimal candidates undergoing sublobar resection. J Thorac Cardiovasc Surg. 2012;144(6):1365\u201371.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"5","key":"5708_CR5","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1016\/j.athoracsur.2014.02.024","volume":"97","author":"Y Tsutani","year":"2014","unstructured":"Tsutani Y, Miyata Y, Nakayama H, Okumura S, Adachi S, Yoshimura M, Okada M. Sublobar resection for lung adenocarcinoma meeting node-negative criteria on preoperative imaging. Ann Thorac Surg. 2014;97(5):1701\u20137.","journal-title":"Ann Thorac Surg"},{"issue":"6917","key":"5708_CR6","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917):860\u20137.","journal-title":"Nature"},{"issue":"7203","key":"5708_CR7","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454(7203):436\u201344.","journal-title":"Nature"},{"issue":"3","key":"5708_CR8","doi-asserted-by":"publisher","first-page":"242","DOI":"10.2174\/0929866530666230112165515","volume":"30","author":"X Zheng","year":"2023","unstructured":"Zheng X, Huang D, Liu X, Liu QY, Gao X, Liu L. GSK3\u03b2\/ITCH\/c-FLIP Axis Counteracts TRAIL-induced Apoptosis in Human Lung Adenocarcinoma Cells. Protein Pept Lett. 2023;30(3):242\u20139.","journal-title":"Protein Pept Lett"},{"issue":"14","key":"5708_CR9","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1093\/jnci\/djr216","volume":"103","author":"SR Pine","year":"2011","unstructured":"Pine SR, Mechanic LE, Enewold L, Chaturvedi AK, Katki HA, Zheng YL, et al. Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer. J Natl Cancer Inst. 2011;103(14):1112\u201322.","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"5708_CR10","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1038\/s41590-023-01588-w","volume":"24","author":"JH Zhao","year":"2023","unstructured":"Zhao JH, Stacey D, Eriksson N, Macdonald-Dunlop E, Hedman AK, Kalnapenkis A, et al. Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets. Nat Immunol. 2023;24(9):1540\u201351.","journal-title":"Nat Immunol"},{"key":"5708_CR11","unstructured":"Burgess S, Thompson SG. Mendelian Randomization: methods for Using Genetic Variants in Causal Estimation. Chapman & Hall\/CRC; 2015."},{"issue":"9","key":"5708_CR12","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1158\/1055-9965.EPI-17-1177","volume":"27","author":"J Yarmolinsky","year":"2018","unstructured":"Yarmolinsky J, Wade KH, Richmond RC, Langdon RJ, Bull CJ, Tilling KM, et al. Causal Inference in Cancer Epidemiology: What Is the Role of Mendelian Randomization? Cancer Epidemiol Biomarkers Prev. 2018;27(9):995\u20131010.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"10","key":"5708_CR13","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1182\/blood.V98.9.2626","volume":"98","author":"MA Wurbel","year":"2001","unstructured":"Wurbel MA, Malissen M, Guy-Grand D, Meffre E, Nussenzweig MC, Richelme M, Carrier A, Malissen B. Mice lacking the CCR9-CCL25 system show a mild impairment of early T- and B-cell development and a reduction in T-cell receptor gammadelta(+) gut intraepithelial lymphocytes. Blood. 2001;98(10):2626\u201332.","journal-title":"Blood"},{"issue":"1","key":"5708_CR14","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41392-024-01868-3","volume":"9","author":"J Li","year":"2024","unstructured":"Li J, Xu J, Yan X, Jin K, Li W, Zhang R. Targeting cytokine and chemokine signaling pathways for cancer therapy. Signal Transduct Target Ther. 2024;9(1):176.","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"5708_CR15","first-page":"1279","volume":"39","author":"C Johnson-Holiday","year":"2011","unstructured":"Johnson-Holiday C, Singh R, Johnson E, Singh S, Stockard CR, Grizzle WE, Lillard JW Jr. CCL25 mediates migration, invasion and matrix metalloproteinase expression by breast cancer cells in a CCR9-dependent fashion. Int J Oncol. 2011;39(5):1279\u201385.","journal-title":"Int J Oncol"},{"key":"5708_CR16","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1477-7819-8-62","volume":"8","author":"EL Johnson","year":"2010","unstructured":"Johnson EL, Singh R, Singh S, Johnson-Holiday CM, Grizzle WE, Lillard JW Jr. CCL25-CCR9 interaction modulates ovarian cancer cell migration, metalloproteinase expression, and invasion. World J Surg Oncol. 2010;8:62.","journal-title":"World J Surg Oncol"},{"issue":"7355","key":"5708_CR17","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nature10169","volume":"475","author":"A Facciabene","year":"2011","unstructured":"Facciabene A, Peng X, Hagemann IS, Balint K, Barchetti A, Wang LP, Gimotty PA, Gilks CB, Lal P, Zhang L, Coukos G. Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells. Nature. 2011;475(7355):226\u201330.","journal-title":"Nature"},{"key":"5708_CR18","first-page":"1569","volume":"3","author":"R Singh","year":"2011","unstructured":"Singh R, Lillard JW Jr, Singh S. Chemokines: key players in cancer progression and metastasis. Front Biosci (Schol Ed). 2011;3:1569\u201382.","journal-title":"Front Biosci (Schol Ed)"},{"issue":"7","key":"5708_CR19","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1158\/1078-0432.CCR-08-2387","volume":"15","author":"S Singh","year":"2009","unstructured":"Singh S, Sadanandam A, Nannuru KC, Varney ML, Mayer-Ezell R, Bond R, Singh RK. Small-molecule antagonists for CXCR2 and CXCR1 inhibit human melanoma growth by decreasing tumor cell proliferation, survival, and angiogenesis. Clin Cancer Res. 2009;15(7):2380\u20136.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"5708_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12916-021-02193-0","volume":"20","author":"S H\u00e4gg","year":"2022","unstructured":"H\u00e4gg S, Jylh\u00e4v\u00e4 J, Wang Y, Czene K, Grassmann F. Circulating inflammatory cytokines and risk of five cancers: a Mendelian randomization analysis. BMC Med. 2022;20(1):3.","journal-title":"BMC Med"},{"issue":"24","key":"5708_CR21","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1093\/jnci\/djt309","volume":"105","author":"MS Shiels","year":"2013","unstructured":"Shiels MS, Pfeiffer RM, Hildesheim A, Engels EA, Kemp TJ, Park JH, et al. Circulating inflammation markers and prospective risk for lung cancer. J Natl Cancer Inst. 2013;105(24):1871\u201380.","journal-title":"J Natl Cancer Inst"},{"key":"5708_CR22","first-page":"1065107","volume":"12","author":"X Jin","year":"2022","unstructured":"Jin X, Zhu Y, Wang L, Zhang J, Feng R, Zhao X. Circulating inflammatory cytokines and non-small cell lung cancer: a Mendelian randomization study. Front Oncol. 2022;12:1065107.","journal-title":"Front Oncol"},{"issue":"2","key":"5708_CR23","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1093\/aje\/kww159","volume":"185","author":"DC Muller","year":"2017","unstructured":"Muller DC, Larose TL, Hodge A, Guida F, Langhammer A, Grankvist K, et al. Inflammatory Cytokines and Lung Cancer Risk in 3 Prospective Studies. Am J Epidemiol. 2017;185(2):86\u201395.","journal-title":"Am J Epidemiol"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05708-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05708-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05708-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T08:37:40Z","timestamp":1789461460000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05708-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,5]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5708"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05708-4","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,5]]},"assertion":[{"value":"13 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not available.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors reviewed and approved the final manuscript.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1334"}}